Liqin Xu
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 5
-
- Temporomandibular Joint Disorders 3
- Molecular Biology top 10%
- Steroid Chemistry and Biochemistry 5
- Genomics and Phylogenetic Studies 4
- Epigenetics and DNA Methylation 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- Anesthesiology and Pain Medicine top 10%
-
- Osteoarthritis Treatment and Mechanisms 4
-
- Pain Mechanisms and Treatments 3
- Journals
- Advanced Materials (1 paper)Journal of Clinical Oncology (1 paper)Bioinformatics (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Liqin Xu
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Pharmacology 248
- Complementary and Manual Therapy 46
- Molecular Biology 909
- Cancer Research 165
- Anesthesiology and Pain Medicine 47
Countries citing papers authored by Liqin Xu
This map shows the geographic impact of Liqin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqin Xu more than expected).
Fields of papers citing papers by Liqin Xu
This network shows the impact of papers produced by Liqin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqin Xu. The network helps show where Liqin Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liqin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 42 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 2017 | 9 | |
| 12 | 2017 | 37 | |
| 13 | 2016 | 108 | |
| 14 | A time-dependent degeneration manner of condyle in rat CFA-induced inflamed TMJ. | 2016 | 45 |
| 15 | 2015 | 28 | |
| 16 | 2014 | 99 | |
| 17 | 2013 | 52 | |
| 18 | 2013 | 7 | |
| 19 | 2013 | 16 | |
| 20 | 2011 | 82 |
About Liqin Xu
Liqin Xu is a scholar working on Complementary and Manual Therapy, Horticulture and Pharmacology, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Steroid Chemistry and Biochemistry (5 papers), Genomics and Phylogenetic Studies (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Cancer Genomics and Diagnostics (3 papers), Pain Mechanisms and Treatments (3 papers), Temporomandibular Joint Disorders (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Pharmacology (248 citations), Complementary and Manual Therapy (46 citations) and Molecular Biology (909 citations). Liqin Xu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Feng‐Qing Wang, Dongzhi Wei, Hao Lin, Wei Chen, En-Ze Deng, Kuo‐Chen Chou, Hui Ding, Yao Kang, Hao-Hao Liu and Youssef Tahiri. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.